Andrew R. Robbins - Jan 25, 2022 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
President and CEO, Director
Signature
/s/ Ryan Murr, Attorney-in-Fact
Stock symbol
COGT
Transactions as of
Jan 25, 2022
Transactions value $
$3,410,808
Form type
4
Date filed
1/27/2022, 04:37 PM
Previous filing
May 14, 2021
Next filing
Jun 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $3.41M +690K $4.94 690K Jan 25, 2022 Common Stock 690K $7.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in equal monthly installments over a four year period.